Research Interests
Prostate Cancer Outcomes
Prostate Specific Antigen
Prostate Cancer Screening
Prostate Cancer Surgery
Prostate Cancer Medical Management
Prostate Specific Antigen
Prostate Cancer Screening
Prostate Cancer Surgery
Prostate Cancer Medical Management
Selected Grants
Phase III Randomized Efficacy and Safety Study
Clinical TrialPrincipal Investigator · Awarded by Medivation, Inc. · 2016 - 2027A Prospective Trial - Evaluation of ExoDx Prostate in Men with Prostate Cancer in an Active Surveillance Regimen
Clinical TrialPrincipal Investigator · Awarded by Exosome Diagnostics, Inc. · 2022 - 2026NWU22-12-01 A PHASE 2 PLACEBO-CONTROLLED TRIAL OF UROLITHIN A SUPPLEMENTATION IN MEN WITH PROSTATE CANCER UNDERGOING RADICAL PROSTATECTOMY
ResearchCo Investigator · Awarded by Northwestern University · 2024 - 2025A Prospective Observational Cohort Study of Patients with Castration Resistant Prostate Cancer
Clinical TrialPrincipal Investigator · Awarded by Astellas Pharma Global Development, Inc · 2015 - 2021Exercise Training, Erectile Dysfunction, and Prostate Cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2013IPA - Jens Dannull
ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2007 - 2008Prostate Cancer Recovery Enhancement (PROCARE) for African American Men
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2007 - 2008IPA Agreement - Jens Dannull
ResearchPrincipal Investigator · Awarded by Veterans Administration Medical Center · 2006 - 2007Expression Analysis of Prostate Cancer's Clinical Behavior
ResearchSponsor · Awarded by National Institutes of Health · 2001 - 2006External Relationships
- Bayer Healthcare Pharmaceuticals/ Physician World
- Best Doctors-Teledoc Health
- Biopharm Communications LLC
- Dava Oncology
- Exosome Diagnostics Inc
- IQVIA-Astellas/Pfizer/J & J
- Medical Leverage -Dendreon
- Theralogix LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.